Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat–an animal model of attention deficit hyperactivity disorder
- 371 Downloads
Cannabis preparations are the most widely consumed illicit drugs, and their use typically begins in adolescence. The prevalence of cannabis abuse is higher in patients with attention deficit/hyperactivity disorder (ADHD) than in the general population, yet, knowledge about the motivational properties of cannabinoids in animal models of ADHD are lacking.
To compare the motivational effects of the synthetic cannabinoid agonist WIN55,212-2 (WIN) in adolescent and adult spontaneously hypertensive rats (SHR), a validated animal model of ADHD, and Wistar rats, representing a “normal” genetically heterogeneous population. We also asked whether the effects of WIN depended (1) on the activation of the cerebral subtype of cannabinoid receptors, namely, the CB1 cannabinoid receptor and (2) on putative changes by WIN in blood pressure.
WIN was tested under an unbiased conditioned place preference (CPP) paradigm. Blood pressure after WIN administration was also monitored in additional groups of rats.
In the Wistar rats, WIN produced place aversion only in the adult but not adolescent rats. In contrast, WIN produced CPP in both adolescent and adult SHR rats. The behavioral effects of WIN were CB1-mediated and not related to blood pressure.
The contrasting effects of WIN in Wistar and SHR, and the higher resistance of adolescent rats to the aversive and rewarding effects of WIN in these two strains suggests that both adolescence and the ADHD-like profile exhibited by the SHR strain constitute factors that influence the motivational properties of cannabinoids.
KeywordsAttention deficit hyperactivity disorder (ADHD) Drug addiction Adolescence Cannabinoid system Dopamine Reward Aversion Conditioned place preference Inbred strain Spontaneously hypertensive rat (SHR)
The authors are grateful to Dr. Jamil Assreuy for his expert assistance in blood pressure measurements and to Dr. Attila Köfalvi and Dr. Kelly J. Clemens for helpful comments. P.P. and R.S. are supported by scholarships from CNPq, Brazil. L.F.V. had a post-doctoral fellowship from FONDATION FYSSEN, France. R.N.T. is the holder of a CNPq fellowship.
- Köfalvi A, Fritzsche M (2008) The Endocannabinoid System is a Major Player in Schizophrenia. In: Köfalvi, A. (Ed.), Cannabinoids and the Brain. Springer US, pp. 485-528. doi: 10.1007/978-0-387-74349-3_22
- McKeon TW, Hendley ED. Brain monoamines and metabolites in hypertensive and hyperactive rat strains. Clin Exp Hypertens. 1988;10:971–994.Google Scholar
- Pandolfo P, Pamplona FA, Prediger RD, Takahashi RN. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55, 212–2. Eur J Pharmacol. 2007;563:141–148.PubMedCrossRefGoogle Scholar
- Papa M, Diewald L, Carey MP, Esposito FJ, Gironi Carnevale UA, Sadile AG. A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system. Behav Brain Res. 2002;130:171–179.PubMedCrossRefGoogle Scholar
- Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, et al. Adolescent rats find repeated delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology. 2008;33:1113–1126.PubMedCrossRefGoogle Scholar
- Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder—the spontaneously hypertensive rat. Brain Res. 1995;676:343–351.PubMedCrossRefGoogle Scholar
- Vendruscolo LF, Izídio GS, Takahashi RN. Drug reinforcement in a rat model of attention deficit/hyperactivity disorder – the spontaneously hypertensive rat (SHR). Current Drug Abuse Reviews. 2009, in pressGoogle Scholar
- Viggiano D, Vallone D, Ruocco LA, Sadile AG. Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci Biobehav Rev. 2003;27:683–689.PubMedCrossRefGoogle Scholar